8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 17, 2014

 

 

Accretive Health, Inc.

(Exact Name of Registrant as Specified in Charter)

 

 

 

Delaware   001-34746   02-0698101

(State or Other Jurisdiction

of Incorporation)

  

(Commission

File Number)

  

(IRS Employer

Identification No.)

 

401 North Michigan Avenue, Suite 2700, Chicago, Illinois   60611
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s telephone number, including area code: (312) 324-7820

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

  ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

  ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

  ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

  ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On April 17, 2014, Stephen F. Schuckenbrock resigned from his position as President and Chief Executive Officer of Accretive Health, Inc. (the “Company”), effective October 2, 2014, which is the expiration date of the current term of his employment agreement. Mr. Schuckenbrock will continue to serve as a director of the Company.

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits

 

  99.1 Press Release issued by the Company on April 23, 2014.

 

2

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    ACCRETIVE HEALTH, INC.
Date:    April 23, 2014     By:   /s/    Sean F. Orr
      Sean F. Orr
      Chief Financial Officer and Treasurer

 

3

EXHIBIT INDEX

 

Exhibit No.

   

Description

99.1    Press Release issued by the Company on April 23, 2014